Zobrazeno 1 - 10
of 615
pro vyhledávání: '"Tamura A"'
Autor:
Masayuki Takeda, Tomohide Tamura, Kohei Akiyoshi, Masahiro Morise, Naofumi Shinagawa, Toshiaki Saeki, Naoki Inui, Morihito Okada, Shunichi Sugawara, Kaoru Kubota, Yasutaka Watanabe, Akito Hata, Isamu Okamoto
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(2)
PURPOSE We evaluated the efficacy and safety of fosnetupitant (FosNTP) versus fosaprepitant (FosAPR) for preventing highly emetogenic chemotherapy-induced nausea and vomiting. This phase III study was the first head-to-head comparison between two dif
Autor:
Yoichiro, Yoshida, Kazuo, Tamura
Publikováno v:
Japanese Journal of Clinical Oncology. 52:449-455
Background A questionnaire survey was conducted to assess the implementation status of geriatric assessment in cancer treatment and the potential for collaboration between medical care and the long-term care insurance system. Methods Questionnaires w
Autor:
Hidetoshi Yasuoka, Atsushi Naganuma, Eishin Kurihara, Tsutomu Kobatake, Masashi Ijima, Yuki Tamura, Yuhei Suzuki, Takashi Hoshino, Fumiya Ishida, Hisashi Hosaka, Takeshi Hatanaka, Sachiko Yoshida, Ryusuke Aihara, Yasuo Hosouchi, Norihiro Ishii, Kenichiro Araki, Ken Shirabe, Toshio Uraoka, Satoru Kakizaki
Publikováno v:
Oncology. 100:449-459
Introduction: This retrospective study investigated the efficacy and safety of nano-liposomal irinotecan (nal-IRI) plus 5-fluorouracil/L-leucovorin (5-FU/l-LV) treatment in the second-line or later setting for advanced pancreatic cancer under real-wo
Autor:
NOBUAKI TAMURA, KAZU MIZUNO, RYUICHIRO SUZUKI, MASAHIRO SUGIMOTO, AYAME ENOMOTO, SANA OTA, MIKU KANEKO, HIROSHI SAKAGAMI, HIROSHI TAKESHIMA
Publikováno v:
In Vivo
Background/Aim: Underwater exercise is aimed at preventing aging, maintaining, and improving motor function, and improving physical function. However, its rehabilitation effects have not been well evaluated. In order to gain insight into the molecula
Autor:
Kenji Wakai, Tetsuya Mizoue, Shiori Tanaka, Tetsuhisa Kitamura, Kotaro Ozasa, Shuhei Nomura, Keitaro Matsuo, Shizuka Sasazuki, Michihiro Muto, Hidekazu Suzuki, Taichi Shimazu, Tomio Nakayama, Yingsong Lin, Norie Sawada, Motoki Iwasaki, Tetsuya Otani, Keitaro Tanaka, Isao Oze, Atsuko Sadakane, Shoichiro Tsugane, Sarah Krull Abe, Mariko Naito, Eiko Saito, Yoshikazu Nishino, Yoshitaka Tsubono, Chisato Nagata, Yumi Sugawara, Keiko Wada, Ayami Ono, Taiki Yamaji, Takashi Tamura, Ichiro Tsuji, Hidemi Ito, Yuri Kitamura, Hadrien Charvat, Akiko Tamakoshi, Mai Utada, Mamami Inoue
Publikováno v:
Cancer Science
The association between alcohol intake and stomach cancer risk remains controversial. We undertook a pooled analysis of data from six large‐scale Japanese cohort studies with 256 478 participants on this topic. Alcohol intake as ethanol was estimat
Autor:
Kenji Tamura, Kazuki Sudo, Hiroshi Yoshida, Takayuki Kinoshita, Tatsunori Shimoi, Kan Yonemori, Jun Hashimoto, Takahiro Fukuda, Yasuhiro Fujiwara, Masayuki Yoshida, Mayu Yunokawa, Chikako Shimizu, Akihiko Shimomura, Emi Noguchi, Tomoyasu Kato
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cancer
BMC Cancer
Background The V-Akt murine thymoma viral oncogene (AKT) 1 (E17K) is a subfamily of serine/threonine protein kinases that affects the survival, proliferation, and invasion of cancer cells. The clinicopathological features and frequencies in Asian pop
Autor:
Takahiko Nakamura, Kenjiro Tsuruoka, Kiyoe Kanaoka, Yosuke Tamura, Yasuhito Fujisaka, Soichiro Ikeda, Tomoya Funamoto, Masafumi Imanishi, Isao Goto, Akihisa Imagawa, Hiroyuki Tsuji, Sho Mitsuya, Ninso Matsunaga
Publikováno v:
Anticancer Research. 41:5137-5145
BACKGROUND For epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), administration of EGFR tyrosine kinase inhibitors (TKIs) is mandatory to prolong survival. To date, a comparison of second- and third-generation EGFR-T
Autor:
Yuta Sekino, Taro Shibata, Hiroji Iwata, Tomonori Mizutani, Akihiko Shimomura, Masataka Sawaki, Tadahiko Shien, Keita Sasaki, Kiyo Tanaka, Kenji Tamura
Publikováno v:
Japanese Journal of Clinical Oncology. 51:1471-1474
The standard first-line treatment for patients with human epidermal growth factor 2-positive metastatic breast cancer is a combination therapy of trastuzumab, pertuzumab and docetaxel, and the standard second-line treatment is trastuzumab emtansine.
Autor:
Kan Yonemori, Nobuko Tamura, Kenji Tamura, Mayu Yunokawa, Yasuhiro Fujiwara, Yuko Tanabe, Junko Hasegawa, Kenji Hashimoto, Kazutaka Ikeda, Toshimi Takano, Daisuke Nishizawa, Akihiko Shimomura, Chikako Shimizu, Seiji Shiraishi, Yukinori Ozaki, Hidetaka Kawabata
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Cancer
BMC Cancer
Background Sodium channels located in the dorsal root ganglion, particularly Nav1.7 and Nav1.8, encoded by SCN9A and SCN10A, respectively, act as molecular gatekeepers for pain detection. Our aim was to determine the association between TIPN and SCN9
Autor:
Hajime Yonezawa, Yoshitaka Narita, Satoshi Shima, Yukie Tamura, Masamichi Takahashi, Yuko Matsushita, Hiroshi Igaki, Yasuji Miyakita, Koichi Ichimura, Makoto Ohno
Publikováno v:
Japanese Journal of Clinical Oncology. 51:1028-1035
Background There is no standard treatment for patients with recurrent high-grade gliomas who progress after bevacizumab treatment. We evaluated the outcomes of re-irradiation combined with bevacizumab for patients refractory to bevacizumab. Methods B